Asthma is caused by a combination of poorly understood genetic and environmental factors 1,2 . We have systematically mapped the effects of single nucleotide polymorphisms (SNPs) on the presence of childhood onset asthma by genome-wide association. We characterized more than 317,000 SNPs in DNA from 994 patients with childhood onset asthma and 1,243 non-asthmatics, using family and case-referent panels. Here we show multiple markers on chromosome 17q21 to be strongly and reproducibly associated with childhood onset asthma in family and case-referent panels with a combined P value of P , 10 212 . In independent replication studies the 17q21 locus showed strong association with diagnosis of childhood asthma in 2,320 subjects from a cohort of German children (P 5 0.0003) and in 3,301 subjects from the British 1958 Birth Cohort (P 5 0.0005). We systematically evaluated the relationships between markers of the 17q21 locus and transcript levels of genes in Epstein-Barr virus (EBV)-transformed lymphoblastoid cell lines from children in the asthma family panel used in our association study. The SNPs associated with childhood asthma were consistently and strongly associated (P , 10 222 ) in cis with transcript levels of ORMDL3, a member of a gene family that encodes transmembrane proteins anchored in the endoplasmic reticulum 3 . The results indicate that genetic variants regulating ORMDL3 expression are determinants of susceptibility to childhood asthma.
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Our study design aimed to provide internal replication of potentially positive results with family and case-referent panels of subjects with childhood asthma (Fig. 1 ). This structure also allowed comparison for consistency between case-control and family-based tests of association. To systematically investigate the effects of polymorphisms on the transcription of positional candidate genes, we further measured global gene expression in B-cell-derived EBV-transformed lymphoblastoid cell lines (EBVL) in probands and siblings of the family panel.
The study subjects included a panel of 207 predominantly (99%) nuclear families (MRC-A). These were recruited through a proband with severe (Step 3) childhood onset asthma and contained 295 sib pairs, 11 half-sib pairs and 3 singletons (counting all possible sibs). Four-hundred and thirty-seven non-asthmatic Caucasian UK controls (UK-C) were studied by the same protocols. We also genotyped 728 children of German origin recruited in the Multicentre Asthma Genetics in Childhood Study (MAGICS) study with physician-diagnosed asthma for comparison with 694 reference children recruited in the cross sectional International Study of Asthma and Allergies in Childhood (ISAAC) study 4 . We genotyped all children in the primary association study with the Illumina Sentrix HumanHap300 BeadChip. After quality control and elimination of markers with low minor-allele frequencies (,0.5%), extreme Hardy-Weinberg equilibrium statistics (x 2 . 25) or low genotyping call rates (,95%), we retained 307,328 SNPs and 684 million genotypes (99.4% call rate) for analysis. Amongst the 2,236,212 common (minimum allele frequency . 0.05) SNPs in the HapMap panel, 79% were tagged with correlation R 2 . 0.8 and 90.9% with R 2 . 0.5 with our successfully typed markers. We also typed the parents and children in the MRC-A panel with the Illumina Sentrix Human-1 Genotyping BeadChip (concentrated on genes and surrounding sequences) (Fig. 1 additional 91,293 SNPs with 36.0% average heterozygosity and 89,815,992 genotypes (99.0% call rate). We found only 0.412 mendelian errors per SNP: these were excluded from subsequent analyses. We tested for association of the 300K panel to childhood onset asthma in the combined primary data set of 994 asthmatics and 1,243 non-asthmatics (Fig. 2) . We calculated the 1% false-discovery rate (FDR) threshold 5 to be P # 6.8 3 10 27 and the 5% FDR to be P # 5.0 3 10 26 . We tested for population stratification in the combined data set, finding a genomic control parameter of 1.07. This minor degree of background stratification reflected small differences in allele frequencies within and between the two nationally defined European populations that contributed to the study.
We further tested the effects of stratification on our top results by analysing the 34 SNPs that surpassed the 5% FDR threshold with 102 randomly selected SNPs as covariates in a backward stepwise logistic regression procedure 6 . The results of the stepwise logistic regression analysis showed only modest reduction of the support for association for 31 of the SNPs. Of 34 SNPs, 16 continued to surpass the 5% FDR and 12 of 20 SNPs remained above the 1% FDR threshold (Supplementary Table 1 ).
Strikingly, 7 of the 12 markers still below the 1% FDR threshold mapped to a 112 kb interval on chromosome 17q21. Several other markers in this interval also showed strong evidence of association (Supplementary Table 2 , Fig. 2 and Fig. 3a ). The SNP with the strongest evidence of association within the interval was rs7216389 (uncorrected P 5 9 3 10
211
). With the exception of the 17q21 locus, none of the markers below the 5% FDR, after controlling for stratification, were within 1 Mb of each other (Supplementary Table 1 ).
The patterns of association for the chromosome 17q21 markers were similar and significant in both the UK family panel and the German case-referent panel (Table 1 and Supplementary Table 2 ). There was no evidence of heterogeneity of the association, or of significant allele frequency differences in cases or controls from the UK and Germany.
We selected 27 markers from the NCBI database of genetic variation (dbSNP) that were within or adjacent to the strongly associated interval for genotyping. These exhibited similar patterns and strengths of association as the genome-wide association (GWA) markers (Supplementary Table 2) .
SNPs from the region that we had typed in whole families in the MRC-A panel showed significant associations in a family-based association test (Supplementary Table 3 ). The most strongly associated marker was rs8067378 (248 informative transmissions, P 5 3 3 10 26 ; odds ratio, 1.84; 95% confidence interval, 1.43-2.42). The pattern of alleles transmitted in excess to affected offspring was consistent with the case-referent association results, further indicating that the association was robust to population stratification.
The trait-associated markers (with P , 10 26 in the combined data set) from chromosome 17q21 fall within a 206.5 kb core containing three consecutive haplotype blocks (linkage disequilibrium coefficient (D') . 0.94 for adjacent markers, D' , 0.82 between blocks), as well as one 'isolated' marker in moderate (D' 5 0.7) linkage disequilibrium with an adjacent marker ( Supplementary Fig. 1 ). Low linkage disequilibrium between markers that showed strong association with the disease trait indicated that multiple variants may independently confer disease susceptibility. We evaluated this hypothesis statistically in a forward stepwise regression potentially incorporating all the genotyped markers between 34.5 and 36.0 Mb on chromosome 17. This identified three SNPs (rs7216389, rs11650680 and rs3859192), which jointly showed strong association to childhood asthma (P , 10 212 ) and contributed statistically independent significant effects (Supplementary Table 4 ). This result is consistent with the possibility that more than one functional SNP underlies the locus or (less likely given the SNP density across this region) the presence of a single functional SNP in incomplete linkage disequilibrium with the typed markers. Further fine-mapping studies will be required to resolve these alternatives.
We further examined the impact of the chromosome 17q21 locus on childhood asthma with the aid of 200 asthmatic cases and 2,120 non-asthmatic controls from within the cross-sectional study population of ISAAC Phase II, recruited in Dresden and Munich. The corresponding DNAs were genotyped for a series of nine markers from across the locus that had shown evidence of association in the GWA (Table 1) . These showed the same trends as observed in the GWA samples (odds ratios ranging from 1.52 to 1.11), and most were significantly associated with disease with P , 0.001 (4 out of 9 markers) or P , 0.01 (5 out of 9 markers).
One chromosome 17q21 SNP associated with childhood asthma in the GWA analysis (rs3894194, Table 1 ) had been previously examined in 3,301 subjects from the UK 1958 birth cohort. The genotype data for this marker were deposited for public use in the database maintained by the investigators responsible for the cohort study (http://www.b58cgene.sgul.ac.uk/). Although data were not available for the other disease-associated chromosome 17q21 markers, we were able to confirm association to childhood asthma with rs3894194, which is in linkage disequilibrium with the other markers at the locus (linkage disequilibrium block 3 in Supplementary Fig. 1 ). Restricting analyses to cohort members of Caucasian ethnicity, we found that the 398 cases recalling 'asthma ever' at age 42, showed a significant association (odds ratio, 1.21, 95% confidence interval, 1.04-1.40, P 5 0.012). Ninety-three individuals were reported to have 'asthma attacks' in the first seven years of life (that is during 1958 to 1965), and these were strongly associated to rs3894194 (odds ratio 5 1.68, 95% confidence interval, 1.25-2.26, P 5 0.0005).
The disease-associated chromosome 17q21 markers had consistent odds ratios and directions of association effects in the GWA panels and the two replication cohorts (P 5 0.19 for heterogeneity) ( Table 1 ), suggesting that we have identified a robust risk factor for childhood asthma.
Variation in gene transcription is an important mechanism in mediating susceptibility to asthma and other diseases, and the transcript abundances of genes may be directly modified by polymorphisms in regulatory elements 7, 8 . We therefore measured global gene expression in EBVL from children in the MRC-A panel (Fig. 1 ). These same subjects had been typed with the Illumina Sentrix HumanHap300 and Sentrix Human-1 Genotyping BeadChips (Fig.  1) . EBVLs represent the B-cell lineage, and are consequently of direct relevance to asthma. Cells were harvested at log-phase in the first growth after EBV transformation. Global transcript abundance was measured with Affymetrix HG-U133 Plus 2.0 chips. We used quantile normalization after Robust Multi-Array Average (RMA) to enforce normality and reduce outlier leverage. A complete description of the global results will be presented in another paper.
Expression data were available for 14 of 19 annotated genes in the region from 35.0 to 35.5 Mb on chromosome 17 (that is, within or near the 206 kb region of association on 17q21.1) (Fig. 3d) . We found that transcripts in one gene, ORMDL3, were strongly (P , 10 222 for rs7216389) and consistently positively associated to exactly the same SNPs from the Illumina Sentrix HumanHap300 BeadChip as childhood asthma (Fig. 3c) . The disease-associated markers accounted for 29.5% of the variance of expression. No other markers were significantly correlated to ORMDL3 expression after adjustment for genome-wide multiple testing. After accounting for the effects of the disease-associated markers, the residual heritability of the ORMDL3 expression was not significant (P 5 0.29 compared to P 5 0.0009 before adjustment).
These findings suggested that the 17q21 disease-associated locus is the principal genetic determinant of ORMDL3 expression. None of the other transcripts from the region or elsewhere in the genome showed a significant relationship to the disease-associated markers in our data set. Despite the strength of these effects, the presence of several SNPs independently associated to asthma nevertheless makes it possible that ORMDL3 may not be the exclusive determinant of the disease susceptibility at this locus.
In the subset of individuals for whom expression data are available, the T nucleotide allele at rs7216389 (the marker most strongly associated with disease in the combined GWA analysis) has a frequency of 62% amongst asthmatics compared to 52% in non-asthmatics (P 5 0.005 in this sample). The additive effect of this allele corresponds to a change of 0.78 standard deviation units in ORMDL3 expression (P , 10 222 ). We saw the expected increase of ,0.064 standard deviation units in ORMDL3 expression among asthmatics, but this was not significant given the sample size. Patterns of ORMDL3 expression by genotype in asthmatics and non-asthmatics are shown in Supplementary Fig. 2 .
ORMDL3 is the third member of a novel class of genes of unknown function that encode transmembrane proteins anchored in the endoplasmic reticulum (ER) 3 . We examined multiple tissue complementary (MTC) DNA panels by PCR with reverse transcription (RT-PCR), and found ORMDL3 to be expressed in many tissues, particularly liver and peripheral blood lymphocytes (Fig. 3g) . The SNPs showing the strongest association to asthma and ORMDL3 transcript abundances are contained within an island of linkage disequilibrium between 35.2 and 35.4 Mb on chromosome 17q21 ( Fig. 3b and 3c) . The one-lod support unit for SNPs showing maximum association to ORMDL3 levels lies within the first intron of the neighbouring GSDML gene. This non-coding sequence shows significant homology between species (Fig. 3e and 3f) , and contains an element with high homology to the pro-inflammatory transcription factor C/EBPb (transcription factor score, 86.8; http://www.cbrc.jp/ research/db/TFSEARCH.html).
Genomic regions other than the 17q21 locus did not contain multiple markers with significant evidence of association at the 1% No template control Table 1 ) passed a less stringent 5% FDR threshold after adjustment for population stratification, indicating that other susceptibility loci for childhood asthma could be present, perhaps having smaller effects than those found on chromosome 17q21. These results will be explored in large scale replication studies in multiple centres and population samples (the GABRIEL project: http://www.gabriel-fp6.org/project).
METHODS SUMMARY
Children and their parents from the UK panels were administered a standard questionnaire 9 by a nurse or doctor. Asthma was defined as a positive response to the question ''Has your doctor ever told you that you have asthma?'' Probands had Step 3 asthma or worse according to British Thoracic Society guidelines 10 . Siblings were included regardless of asthma status 11 . Asthma cases from the MAGICS were diagnosed by a paediatric pulmonologist or allergologist on the basis of clinical examination, history and objective tests of lung function. The transformation of peripheral blood lymphocytes in all children in the MRC-A panel was carried out by the ECACC (http://www.ecacc.org.uk). Microarray hybridization of EBVL RNA to the U133 Plus 2.0 GeneChips (Affymetrix) was under standard conditions. Whole-genome genotyping was carried out using Illumina Sentrix Human-1 Genotyping BeadChip 12 and Sentrix HumanHap300 Genotyping BeadChips 13 (Illumina, San Diego). Genotyping of additional markers was performed on an ABI7900HT Sequence Detection System using TaqMan probes (Applied Biosystems, Foster City, California). German replication samples were genotyped using matrix-assisted laser desorption/ionizationtime of flight (http://www.sequenom.com) 14 . Logistic regression models with robust sandwich estimation of the variance 15 implemented in the Stata logit function were used to detect association to asthma in the combined panels. The TRANSMIT program 16 was used to analyse nuclear family data (including parental genotypes). The false-discovery rate (FDR) method 5 was used to assess the overall statistical significance of the genome-wide association results, and FDR thresholds were calculated by applying the QVALUE (http://faculty. washington.edu/,jstorey/qvalue/) package 17 . Gene expression data were normalized with the RMA package 18, 19 to remove any technical or spurious background variation. An inverse normalization transformation step was also applied to each trait to avoid any outliers. Association analysis was applied with Merlin (FASTASSOC option) 20 , after probabilistically inferring missing genotypes 21 .
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